Orange Book product · Brand (NDA)
NEXICLON XR
CLONIDINE
At a glance
Dec 03, 2009
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 03, 2009
16 yr 9 mo ago
Today
Patent 8337890 expires
Listed drug product patent expiration.
Apr 17, 2027
in 10 mo
Patent 8623409 expires
Listed drug product patent expiration.
Sep 08, 2031
in 5 yr 4 mo
Pharmaceutical detail
Active ingredient
CLONIDINE
Strength
EQ 0.17MG BASE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 022500
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2009CLONIDINEBrand (NDA)
NDA 022499 · TRIS PHARMA INC
- 1984CATAPRES-TTS-1Brand (NDA)
NDA 018891 · LAVIPHARM
- 2014CLONIDINEGeneric (ANDA)
ANDA 090873 · ACTAVIS LABS UT INC
- 2010CLONIDINEGeneric (ANDA)
ANDA 079090 · DR REDDYS LABS SA
- 2010CLONIDINEGeneric (ANDA)
ANDA 076166 · MYLAN TECHNOLOGIES
- 2009CLONIDINEGeneric (ANDA)
ANDA 076157 · DIFGEN PHARMS
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8337890 | Apr 17, 2027 | in 10 mo | Product |
| 8623409 | Sep 08, 2031 | in 5 yr 4 mo | Product |

